Group 1D: Brain Metastasis; Novel Targets

Poster #PS11-06: Analysis of HER2 expression changes from breast primary to brain metastases including HER2 Low and impact on overall survival.

Poster #PO3-06-12: Targeting fatty acid synthase in brain metastatic triple-negative breast cancer.